Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02999009
Other study ID # 78
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 20, 2017
Est. completion date March 2031

Study information

Verified date December 2023
Source Stryker Orthopaedics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 383
Est. completion date March 2031
Est. primary completion date March 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: A. Patient has signed an Institutional Review Board (IRB) approved, study specific Informed Patient Consent Form. B. Patient is a male or non-pregnant female age 18-80 years of age at the time of study device implantation. C. Patient has primary diagnosis of Non-Inflammatory Degenerative Joint Disease. D. Patient is a candidate for a primary cementless total hip replacement. E. Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations. Exclusion Criteria: F. Patient has a Body Mass Index (BMI) = 40. G. Patient is diagnosed with Inflammatory Arthritis. H. Patient has an active or suspected latent infection in or about the affected hip joint at time of study device implantation. I. Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device. J. Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration. K. Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. > 30 days). L. Patient requires revision surgery of a previously implanted total hip replacement or hip fusion to the affected joint. M. Patient has had previous open surgery to the affected joint, not including arthroscopy. N. Patient requires implantation of a constrained liner. O. Patient has a known sensitivity to device materials. P. Patient is a prisoner.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Trident II Tritanium Acetabular Shell
A hemispherical acetabular shell indicated for cementless application.

Locations

Country Name City State
United States UNC Orthopaedics Chapel Hill North Carolina
United States American Hip Institute Des Plaines Illinois
United States Rothman Institute Egg Harbor Township New Jersey
United States Southeast Orthopedic Specialists Jacksonville Florida
United States Center for Orthopaedics and Spine, LLC Lake Charles Louisiana
United States Hospital for Special Surgery New York New York
United States Northwell Health, Lenox Hill Hospital New York New York
United States Tucson Orthopaedic Institute Tucson Arizona
United States St. Joseph Mercy Hospital Health System Ypsilanti Michigan

Sponsors (1)

Lead Sponsor Collaborator
Stryker Orthopaedics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Absence of Revision for the Trident II Tritanium Acetabular Shell 5 years
Secondary All-cause Revision and Removal Rates for the Trident II Tritanium Acetabular Shell Survivorship percentage (one reported value) for both all-cause revision + removal will be indicated 10 years
Secondary Radiographic Stability Numerous parameters will be reviewed by zone, including radiolucency and migration. 6 weeks, 3-6 months, 1, 2, 5, 7, 10 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Recruiting NCT03746925 - Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches N/A
Completed NCT03008967 - A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark N/A
Completed NCT00980616 - Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA) Phase 2
Not yet recruiting NCT00958945 - Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements N/A
Completed NCT04542174 - PMCF 8 Year Results TRJ®
Not yet recruiting NCT04019925 - Assessing the Wear Rates of the ADM/MDM Hips Using 3D X-ray Analysis N/A
Recruiting NCT06102811 - Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty N/A
Recruiting NCT03570944 - Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
Recruiting NCT02938962 - Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X) Phase 4
Completed NCT03076827 - Effects of Surgery Start Time on Postoperative Interleukin-6, Interleukin-8, and Cortisol N/A
Recruiting NCT02385383 - An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study N/A
Completed NCT01444586 - Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE) N/A
Terminated NCT02525627 - A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads N/A
Completed NCT00808483 - Walking Skill Training Program Effects in Patients With Total Hip Arthroplasty N/A
Terminated NCT00958347 - Omnifit Hydroxylapatite (HA) Hip Outcomes Study N/A
Completed NCT01422304 - Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038) Phase 3
Completed NCT04332055 - RCT Measuring the Effect of the ERVIN Software N/A
Completed NCT01257568 - Rejuvenate Modular Outcomes Study N/A
Recruiting NCT01031732 - Evaluation of Four Surgical Techniques in Primary Total Hip Arthroplasty N/A